LLY

901.29

-0.96%↓

JNJ

235.03

-0.28%↓

ABBV

204.68

-0.16%↓

NVS

148.56

+0.66%↑

AZN

185.31

+0.58%↑

LLY

901.29

-0.96%↓

JNJ

235.03

-0.28%↓

ABBV

204.68

-0.16%↓

NVS

148.56

+0.66%↑

AZN

185.31

+0.58%↑

LLY

901.29

-0.96%↓

JNJ

235.03

-0.28%↓

ABBV

204.68

-0.16%↓

NVS

148.56

+0.66%↑

AZN

185.31

+0.58%↑

LLY

901.29

-0.96%↓

JNJ

235.03

-0.28%↓

ABBV

204.68

-0.16%↓

NVS

148.56

+0.66%↑

AZN

185.31

+0.58%↑

LLY

901.29

-0.96%↓

JNJ

235.03

-0.28%↓

ABBV

204.68

-0.16%↓

NVS

148.56

+0.66%↑

AZN

185.31

+0.58%↑

Home・Aandelen Lijst・Vivani Medical

Vivani Medical

Gesloten

1.12 -5.08

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

1.1

Max

1.16

Belangrijke statistieken
By Trading Economics
Inkomsten	614K -6.5M
Werknemers	37

Dividenden
By Dow Jones
Volgende Winsten	30 mrt 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-25M 79M
Vorige openingsprijs	6.2
Vorige sluitingsprijs	1.12

Vivani Medical Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

24 mrt 2026, 18:58 UTC

Belangrijke Marktbewegers

MDA Space Shares Drop After NASA Shifts Focus to Moon's Surface and Away From Space Station

24 mrt 2026, 23:48 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

24 mrt 2026, 23:48 UTC

Marktinformatie

Nikkei May Rise on Hopes for U.S.-Iran Talks -- Market Talk

24 mrt 2026, 23:33 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Gold Rises, Boosted by Dollar Weakness -- Market Talk

24 mrt 2026, 23:16 UTC

Marktinformatie

Venezuelan Opposition Leader Says Oil Output Could Reach 5 Million B/D -- Market Talk

24 mrt 2026, 22:40 UTC

Winsten

Shanghai Fosun Pharmaceutical: Results Supported by Higher Rev From Innovative Drugs, Overseas Business >2196.HK

24 mrt 2026, 22:40 UTC

Winsten

Shanghai Fosun Pharmaceutical 2025 Net CNY3.37B Vs. Net CNY2.77B >2196.HK

24 mrt 2026, 22:40 UTC

Winsten

Shanghai Fosun Pharmaceutical 2025 Rev CNY41.50B Vs. CNY40.91B >2196.HK

24 mrt 2026, 21:44 UTC

Marktinformatie

Global Equities Roundup: Market Talk

24 mrt 2026, 21:44 UTC

Marktinformatie

Sandfire's New Bull Excited by Kalkaroo Copper Deposit -- Market Talk

24 mrt 2026, 20:59 UTC

Winsten

Medtronic PLC Cuts FY26 View To Adj EPS $5.50-Adj EPS $5.54 >MDT

24 mrt 2026, 20:58 UTC

Belangrijke Nieuwsgebeurtenissen

Israel Hits Russian-Iranian Weapons Smuggling Route in the Caspian Sea -- WSJ

24 mrt 2026, 20:50 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Energy & Utilities Roundup: Market Talk

24 mrt 2026, 20:50 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Basic Materials Roundup: Market Talk

24 mrt 2026, 20:50 UTC

Marktinformatie

Financial Services Roundup: Market Talk

24 mrt 2026, 20:25 UTC

Winsten

This Palantir-Linked Drone Stock Was Flying Under the Radar -- Until Now -- Barrons.com

24 mrt 2026, 20:15 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Global Commodities Roundup: Market Talk

24 mrt 2026, 20:10 UTC

Marktinformatie

Canada Mortgage Arrears Linked to Labor Market Performance -- Market Talk

24 mrt 2026, 20:10 UTC

Winsten

Worthington Enterprises 3Q Sales $378.7M >WOR

24 mrt 2026, 20:10 UTC

Winsten

Worthington Enterprises 3Q Adj EPS 98c >WOR

24 mrt 2026, 20:10 UTC

Winsten

Worthington Enterprises 3Q EPS 92c >WOR

24 mrt 2026, 19:25 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Canada Needs Roughly 100 Days to Meet IEA's Oil-Stock Release -- Market Talk

24 mrt 2026, 19:06 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Oil Futures Regain Ground As Strikes Continue in Middle East -- Market Talk

24 mrt 2026, 18:51 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

U.S. Natural Gas Settles Higher As Oil Futures Gain -- Market Talk

24 mrt 2026, 18:40 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Global Forex and Fixed Income Roundup: Market Talk

24 mrt 2026, 18:40 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Mideast Conflict to Hobble But Not Derail Canadian Economy -- Market Talk

24 mrt 2026, 18:34 UTC

Belangrijke Nieuwsgebeurtenissen

Oil Production in the Middle East Will Take Months to Come Back, CEO says. Why $100 Oil Could Be Here to Stay. -- Barrons.com

24 mrt 2026, 18:27 UTC

Marktinformatie

Inflation Pickup Could Keep Bank of Mexico on Hold -- Market Talk

24 mrt 2026, 18:21 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Silver Snaps 9-Session Losing Streak -- Market Talk

24 mrt 2026, 18:00 UTC

Acquisities, Fusies, Overnames

Gilead to Buy Ouro Medicines for $2.2 Billion. Why the Deal Is Key to Future Stock Gains. -- Barrons.com

Peer Vergelijking

Prijswijziging

Vivani Medical Prognose

Beoordelingsconsensus

By TipRanks

0 ratings

Buy

Hold

Sell

Gebaseerd op 0 analisten die aandelenratings hebben gegeven aan Vivani Medical - Dist in de afgelopen 3 maanden.

Financieel

Verkoop- en administratiekosten

Winst voor belastingen

Verkoop

Operationele winst

Over Vivani Medical

Vivani Medical, Inc., a preclinical stage biopharmaceutical company, engages in the development of miniaturized and subdermal implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease, medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in preclinical stage development for the treatment of chronic weight management in patients with obesity or overweight; NPM-119, an exenatide implant candidate is in preclinical stage development for the treatment of patients with type 2 diabetes; NPM-139, a miniature, subdermal GLP-1 implant in development for chronic weight management; and OKV-119, an exenatide implant is under development for metabolic diseases in cats including for the treatment of obesity and diabetes. The company is headquartered in Alameda, California.